Table 1 Participants’ sociodemographic characteristics, vaccination status, smoking habits, and pre-existing medical conditions subdivided by outcome
Dataset 1 (n = 2,623) | SARS-CoV-2 infection (n = 287) | Dataset 2 (n = 2,618) | Moderate-to-severe SARS-CoV-2 infection (n = 60) | Mild SARS-CoV-2 infection (n = 222) | Censored (n = 2,336) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age* (mean, SD) | 49.57 | 16.89 | 42.52 | 15.03 | 49.59 | 16.86 | 40.33 | 13.13 | 43.18 | 15.44 | 50.44 | 16.88 |
Age groups | ||||||||||||
18–34 years (n, %) | 619 | 23.6% | 95 | 33.1% | 617 | 23.6% | 22 | 36.7% | 71 | 32.0% | 524 | 22.4% |
35–59 years old (n, %) | 1,226 | 46.7% | 152 | 53.0% | 1,223 | 46.7% | 34 | 56.7% | 115 | 51.8% | 1,074 | 46.0% |
60–74 years old (n, %) | 576 | 22.0% | 34 | 11.8% | 576 | 22.0% | 4 | 6.7% | 30 | 13.5% | 542 | 23.2% |
75 years or older (n, %) | 202 | 7.7% | 6 | 2.1% | 202 | 7.7% | 0 | 0.0% | 6 | 2.7% | 196 | 8.4% |
Missing values (n, %) | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
Sex* | ||||||||||||
Female (n, %) | 1,408 | 53.7% | 170 | 59.2% | 1,404 | 53.6% | 45 | 75.0% | 121 | 54.5% | 1,238 | 53.0% |
Male (n, %) | 1,215 | 46.3% | 117 | 40.8% | 1,214 | 46.4% | 15 | 25.0% | 101 | 45.5% | 1,098 | 47.0% |
Missing values (n, %) | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0.0 | 0.0% |
BodyMassIndex (mean, SD) | 25.45 | 4.74 | 25.34 | 4.96 | 25.54 | 4.74 | 25.74 | 5.99 | 25.27 | 4.70 | 25.46 | 4.71 |
BodyMassIndex groups | ||||||||||||
< 18.5 (n, %) | 41 | 1.6% | 9 | 3.1% | 41 | 1.6% | 3 | 5.0% | 6 | 2.7% | 32 | 1.4% |
18.5–24.9 (n, %) | 1,351 | 51.5% | 145 | 50.5% | 1,348 | 51.5% | 29 | 48.3% | 113 | 50.9% | 1,206 | 51.6% |
25-29.9 (n, %) | 799 | 30.5% | 85 | 29.6% | 798 | 30.5% | 15 | 25.0% | 69 | 31.1% | 714 | 30.6% |
≥ 30 (n, %) | 380 | 14.5% | 46 | 16.0% | 380 | 14.5% | 13 | 21.7% | 33 | 14.9% | 334 | 14.3% |
Missing values (n, %) | 52 | 2.0% | 2 | 0.7% | 51 | 1.9% | 0 | 0.0% | 1 | 0.5% | 50 | 2.1% |
Vaccination status# | ||||||||||||
Primary immunization w/o booster (n, %) | 262 | 10.0% | 112 | 39.0% | 258 | 9.9% | 21 | 35.0% | 87 | 39.2% | 150 | 6.4% |
Primary immunization w/ booster (n, %) | 2,361 | 90.0% | 175 | 61.0% | 2,360 | 90.1% | 39 | 65.0% | 135 | 60.8% | 2,186 | 93.6% |
Missing values | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
Smoking | ||||||||||||
Yes (n, %) | 543 | 20.7% | 66 | 23.0% | 541 | 20.7% | 20 | 33.3% | 44 | 19.8% | 477 | 20.4% |
No (n, %) | 2,074 | 79.1% | 221 | 77.0% | 2,071 | 79.1% | 40 | 66.7% | 178 | 80.2% | 1,853 | 79.3% |
Missing values (n, %) | 6 | 0.2% | 0 | 0.0% | 6 | 0.2% | 0 | 0.0% | 0 | 0.0% | 6 | 0.3% |
Chronic lung disease | ||||||||||||
Yes (n, %) | 218 | 8.3% | 18 | 6.3% | 216 | 8.3% | 11 | 18.3% | 5 | 2.3% | 200 | 8.6% |
No (n, %) | 2,405 | 91.7% | 269 | 93.7% | 2,402 | 91.7% | 49 | 81.7% | 217 | 97.7% | 2,136 | 91.4% |
Missing values (n, %) | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
Cardiovascular disease | ||||||||||||
Yes (n, %) | 627 | 23.9% | 49 | 17.1% | 626 | 23.9% | 11 | 18.3% | 37 | 16.7% | 578 | 24.7% |
No (n, %) | 1,996 | 76.1% | 238 | 82.9% | 1,992 | 76.1% | 49 | 81.7% | 185 | 83.3% | 1,758 | 75.3% |
Missing values (n, %) | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
Immunodeficiency | ||||||||||||
Yes (n, %) | 69 | 2.6% | 8 | 2.8% | 68 | 2.6% | 0 | 0.0% | 7 | 3.2% | 61 | 2.6% |
No (n, %) | 2,554 | 97.4% | 279 | 97.2% | 2,550 | 97.4% | 60 | 100.0% | 215 | 96.8% | 2,275 | 97.4% |
Missing values** (n, %) | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
Cancer present or treated in the last year | ||||||||||||
Yes (n, %) | 64 | 2.4% | 5 | 1.7% | 64 | 2.4% | 1 | 1,7% | 0 | 0.0% | 59 | 2.5% |
No (n, %) | 2,559 | 97.6% | 282 | 98.3% | 2,554 | 97.6% | 59 | 98.3% | 222 | 100.0% | 2,277 | 97.5% |
Missing values (n, %) | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |